Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system

Pharmaceutical Development and Technology

Volumn 14, Issue 1, 2009, Pages 65-72

  Patel, Mayur M ^a   Shah, Tejal J ^a   Amin, Avani F ^a,c   Shah, Nitesh N ^b  

^a NIRMA UNIVERSITY   (India)

^b Shree Swaminarayan Sanskar Pharmacy College   (India)

^c NIRMA UNIVERSITY   (India)

Author keywords

Colonic drug delivery; Crohn's disease; Eudragit L100; HPMC K4M; Ulcerative colitis

Indexed keywords

EUDRAGIT L100; GLUCOSE; HYDROXYPROPYLMETHYLCELLULOSE; MESALAZINE; POLYMER; POVIDONE; UNCLASSIFIED DRUG;

ARTICLE; COLON TARGETED DRUG DELIVERY SYSTEM; CONTROLLED DRUG RELEASE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENTERIC COATED TABLET; OUTCOME ASSESSMENT; PH; PRIORITY JOURNAL; TABLET COMPRESSION; TIMED DRUG RELEASE;

EID: 61649121922     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450802409412     Document Type: Article

References (31)

1. Lee VHL. Changing needs in drug delivery in the era of peptide and protein drugs. In: Lee VHL, editor. Peptide and Protein Drug Delivery. New York: Marcel Dekker: 1991:1-56.
2. Wood E, Wilson CG, Hardy JG. The spreading of foam and solution enemas. Int. J. Pharm. 1985;25:191-197.
3. Patel M, Shah T, Amin A. Therapeutic opportunities in colon specific drug delivery system. Crit. Rev. Ther. Drug. Carrier. Syst. 2007;24:147-202.
4. Gang C, Feng A, Mei-Juan Z, Jin S, Xiu-Hua H, Yun-Xia H. Time and pH-dependent colon specific drug delivery for orally administered diclofenac sodium and 5 aminosalicylic acid. World J. Gastroenterol. 2004;10:1769-1774.
5. Kinget R, Kalala W, Vervoort L, Van den Mooter G. Colonic drug targeting. J. Drug Target. 1998;6:129-149.
6. Qi ML, Wu DZ. Design and in vivo evaluation of colonic drug delivery systems. Chinese J. Clin. Pharm. 2000;16: 150-154.
7. Watts PJ, Illum L. Colonic drug delivery. Drug. Dev. Ind. Pharm. 1997;23:893-913.
8. Sinha VR, Kumaria R. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 2001;224:19-38.
9. Ahrabi SF, Madsen G, Dyrstad K, Sande SA, Graffner C. Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur. J. Pharm. Sci. 2000;10:43-52.
10. Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL. Design of micro-encapsulate chitosan microspheres for colonic drug delivery. J. Control. Rel. 1998;52:109-118.
11. McLeod AD, Friend DR, Tozer TN. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J. Pharm. Sci. 1994;83:1284-1289.
12. McLeod AD, Tolentino L, Tozer TN. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady state pharmacokinetics in the rat. Biopharm. Drug. Dispos. 1994;15:151-161.
13. Rodriguez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J. Control. Rel. 1998 ;55:67-77.
14. Wilding IR, Davis SS, Pozzi F. Enteric coated timed release system for colonic targeting. Int. J. Pharm. 1994;111:99-102.
15. Macleod GS, Fell JT, Collett JH, Sharma HL, Smith AM. Selective drug delivery to the colon using pectin: chitosan: hydroxypropylmethylcellulose film coated tablets. Int. J. Pharm. 1999;87:251-257.
16. Kun NA, You HB. pH sensitive polymers for drug delivery. In: Glen SK, editor. Polymer Drug Delivery Systems. Florida: Taylor and Francis; 2005:129-194.
17. Khan MZI, Prebeg Z, Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers: I. Manipulation of drug release using Eudragit® L100-55 and Eudragit® S100 combinations. J. Control. Rel. 1999;58:215-222.
18. Khan MZI, Helena PST, Nevenka K. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit® L100 and Eudragit® S100 combinations. Drug. Dev. Ind. Pharm. 2000;26:549-554.
19. Nugent SG, Kumar D, Rampton DS, Evans D. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut. 2001;48:571-577.
20. Bussemer T, Otto I, Bodmeier R. Pulsatile drug delivery systems. Crit. Rev. Ther. Drug. Carrier. Syst. 2001;18:433-458.
21. Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Rel. 2001;73:103-110.
22. Krogel I, Bodmeier R. Floating pulsatile drug delivery systems based on coated effervescent cores. Int. J. Pharm. 1999;187:175-184.
23. Gazzaniga A, Iamartino P, Maffione G, Sangalli ME. Oral delayed-release system for colonic specific delivery. Int. J. Pharm. 1994;108:77-83.
24. Gazzaniga A, Sangalli ME, Giordano F. Oral Chronotopic® drug delivery systems: achievement of time and/or site specificity. Eur. J. Pharm. Biopharm. 1994; 40:246-250.
25. Pozzi F, Furlani P, Gazzaniga A, Davis SS, Wilding IR. The Time-Clock® system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Rel. 1994;31:99-108.
26. Gupta SK, Atkinson L, Theeuwes F, Wong P, Gilbert PJ, Longstreth J. Pharmacokinetics of verapamil from an osmotic system with delayed onset. Eur. J. Pharm. Biopharm. 1996;42:74-81.
27. MacNeil ME, Rashid A, Stevens HNE. Dispensing device. World Patent. WO 9009168. 1990.
28. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HL, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. Bombay: Varghese Publishing House; 1987:293-344.
29. Sinha VR, Kumria R. Coating polymers for colon specific drug delivery: a comparative in vitro evaluation. Acta Pharm. 2003;53:41-47.
30. Bolton S, Charles B. Pharmaceutical Statistics. New York: Marcel Dekker; 2004:506-539.
31. Krishnaiah YSR, Satyanarayana S. Colon specific drug delivery system. In: Jain NK, editor. Advances in Controlled and Novel Drug Delivery. New Delhi: CBS Publishers and Distributors; 2001:89-119.